Exploration Capital, LLC's Form 4 filing
Fresh Tracks Therapeutics, Inc.FRTX · filed May 20, 2024
- Accession no.
- 0001213900-24-045315
- Filed
- May 20, 2024
- Trade date
- May 16-20, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $68.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Exploration Capital, LLCCIK 0002003514 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 16, 2024 | Common Stock | PPurchaseAcquired | +73,768 | $0.92 | +$67,866.56 | 1,299,792 | Direct | |
| May 20, 2024 | Common Stock | PPurchaseAcquired | +797 | $0.91 | +$725.27 | 1,300,589 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.